Gates Scholar’s contribution to diabetes research

  • June 28, 2010

A Gates Scholar is a joint first author of a new paper on the effects of diabetes, published in The Lancet.

The article, published in this week’s issue of The Lancet, shows that diabetes approximately doubles the risk of a wide range of blood vessel diseases, including heart attacks and different types of stroke.

The research is based on an analyisis of 700,000 people, each of whom was monitored for about a decade in 102 surveys conducted in 25 countries. The analysis was made by an international consortium led by Cambridge’s Dr Nadeem Sarwar and Professor John Danesh in the Cardiovascular Epidemiology Unit.

Rao Kondapally Seshasai is a joint first author of this research, which will also be presented at the American Diabetes Association’s 70th Scientific Sessions in Orlando, Florida.

Rao features also this week, alongside Gates Scholar Sebhat Erqou, in research published in the Archives of Internal Medicine on the use of statins. Contrary to previous reports based on more limited data, the research has found that short-term use of statins in patients without a history of heart attacks and strokes has only a borderline effect.

Latest News

Using Computational Chemistry to make better therapeutics

Aidyn Taishybay [2026] believes firmly that science should make a tangible difference to people.  He wants his work to have direct impact in the world and to make medicines more […]

How do we lead with hope?

Two Gates Cambridge Scholars feature in the final episode of the third series of our podcast So, now what? with a discussion about how to lead with hope. This series […]

The path to democratising algorithmic whispers

Cong Minh Nguyen is an economist who wants to tell stories about how market systems shape people’s lives and how they can be redesigned to expand fairness and opportunity.  He […]

How can we reduce the impact of anti-microbial resistance?

John Wang [2026] believes that the efficiency of a drug treatment is not solely determined by the drug itself, but by how precisely its delivery, targeting and release can be […]